Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 60 /hr
Hire Dr. Gloria V.
Switzerland
USD 60 /hr
Pre-Clinical/Clinical Project Manager & Scientific Writer | 15 years experience in multidisciplinary R&D
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting,
Newswriting
Research
Market Research,
User Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Data Processing
Product Development
Product Evaluation,
Concept Development,
Prototyping
Work Experience
Independent Consultant
VeNaV Consulting
June 2021 - Present
Scientist & Regulatory affairs
IVAG
December 2019 - May 2021
Project Representative in Drug Development
Merck KGaA
January 2017 - November 2019
Scientist
Merck KGaA
January 2016 - December 2016
Post-Doctoral Fellow in Pharmacology
Max Planck Institute of Molecular Physiology
December 2011 - July 2015
PhD Fellow in Drug Discovery
Spanish National Research Council (CSIC)
December 2006 - October 2011
Education
PhD
University of Barcelona
January 2007 - November 2011
M.Sc (Master of Science)
University of Barcelona
October 2006 - January 2008
Bachelor of Science (B.Sc) Chemistry
Autonomous University of Barcelona
September 2002 - June 2006
Certifications
-
Certification on Medical Device Regulation (MDR)
TüV Süd Akademie
February 2020 - Present
-
Pharmacokinetics/Pharmacodynamics (PKPD)
DMDG
May 2019 - Present
-
Clinical Pharmacology: Pharmacokinetics/Pharmacodynamics in Drug development
RW Biosciences LTD
November 2018 - Present
-
Pharmacokinetics basics
PK Workshops
July 2017 - Present
-
Business presentations
HPS Germany
October 2016 - Present
Publications
JOURNAL ARTICLE
Vendrell-Navarro, G., Scheible, H., Lignet, F., Burt, H., Luepfert, C., Marx, A., Abla, N., Swart, P., Perrin, D.(2020). Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450–Mediated Drug-Drug Interaction . Drug Metabolism and Disposition. 48. (6). p. 481-490.
Villoslada, P., Vila, G., Colafrancesco, V., Moreno, B., Fernandez-Diez, B., Vazquez, R., Pertsovskaya, I., Zubizarreta, I., Pulido-Valdeolivas, I., Messeguer, J., et al.(2019). Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation . Neurotherapeutics. 16. (3). p. 808-827.
Schneidewind, T., Kapoor, S., Garivet, G., Karageorgis, G., Narayan, R., Vendrell-Navarro, G., Antonchick, A.P., Ziegler, S., Waldmann, H.(2019). The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype . Cell Chemical Biology. 26. (4). p. 512-523.e5.
Vendrell-Navarro, G., Rúa, F., Bujons, J., Brockmeyer, A., Janning, P., Ziegler, S., Messeguer, A., Waldmann, H.(2015). Positional Scanning Synthesis of a Peptoid Library Yields New Inducers of Apoptosis that Target Karyopherins and Tubulin . ChemBioChem. 16. (11). p. 1580-1587.
Messeguer, J., Cortés, N., García-Sanz, N., Navarro-Vendrell, G., Ferrer-Montiel, A., Messeguer, A.(2008). Synthesis of a positional scanning library of pentamers of N-alkylglycines assisted by microwave activation and validation via the identification of trypsin inhibitors . Journal of Combinatorial Chemistry. 10. (6). p. 974-980.
BOOK
Vendrell-Navarro, G., Brockmeyer, A., Waldmann, H., Janning, P., Ziegler, S.(2015). Identification of the targets of biologically active small molecules using quantitative proteomics . Methods in Molecular Biology. 1263. p. 263-286.
OTHER
Glòria Vendrell-Navarro, Andreas Brockmeyer, Herbert Waldmann, Petra Janning, Slava Ziegler(2014). Identification of the Targets of Biologically Active Small Molecules Using Quantitative Proteomics . Methods in Molecular Biology. p. 263--286. Springer New York
PATENT
Moreno, B.V., P.; Navarro, G.; Messeguer, J.; Messeguer, A., New peptoid agonists of nerve growth factor receptor and their use as medicaments. WO/2011/024079. 2011.
Moreno, B.V., P.; Navarro-Vendrell, G.; Messeguer, J.; Messeguer, A., 3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments. WO 2011/024078 A1. 2011.